RALEIGH, N.C., Nov. 2, 2016 /PRNewswire/ -- Raleigh-based Wake Research (Wake Research Associates, LLC) announces a partnership with Western Neurosurgery, Ltd., an affiliated partner of Carondelet Neurological Institute, headquartered in Tucson, Arizona. Tucson Neuroscience Research brings the total number of Wake-owned and affiliated sites to 19, located in seven states in the South-West, Mid-South and Southeastern United States. Wake Research is a wholly owned integrated network of clinical research sites consisting of 110+ physicians / clinical investigators associated with large private practices and large multi-specialty healthcare institutions. This strategic partnership positions Tucson Neuroscience Research to meet pharmaceutical and biotech industry needs for quality sites capable of hosting trials for wide range of neurological disorders. Wake Research and its partners conduct clinical trials in all major therapeutic areas with particular emphasis on internal medicine, dermatology, women's health, metabolic diseases, gastroenterology, men's health, neurology, pulmonology, rheumatology, and vaccine trials. Wake Research conducts clinical trials in all phases (1 thru 4) and owns and operates Carolina Phase 1, a dedicated phase 1 and pharmacokinetic unit located in Raleigh, NC. "Through the creation of Tucson Neurosciences Research, Western Neurosurgery is able to partner with Wake Research Associates to improve patient care. This partnership will strengthen Western Neurosurgery's position as the premier neurosurgery and neurology practice in southern Arizona. Tucson Neurosciences Research will allow Western Neurosurgery to provide better care for our patients now and help develop treatments for patients in the future," said Christopher Shireman, CEO, Western Neurosurgery, Ltd. Wake Research President and Chief Medical Officer, Ella Grach MD says the partnership fits with the strategic vision for Wake Research. "We found in Western Neurosurgery the same dedication to patient well-being and community health that Wake Research pursues," said Dr. Grach. "The Neuro group's desire to provide a personal touch to all aspects of patient care while also focusing on providing cutting edge research opportunities to the patients they serve, aligns well with Wake Research and our core values of excellence, quality and dedication. The physicians at Western Neurosurgery share our commitment to bringing study sponsors together with volunteers to help advance clinical research of new medicines and devices through the clinical trials process to final approval." In addition to a proprietary research database of 800,000 clinical trial participants, Wake Research has its own, in-house marketing and advertising agency, Research, Marketing & Advertising, which leverages outreach to more than 10.7 million individuals in our communities.